NCT04955184

Brief Summary

Invasive pulmonary capillary wedge pressure measurements using a Swan-Ganz catheter (SGC) is considered the gold standard for cardiac output (CO) monitoring. In this prospective study, we will compare CO measurements between a PPG-based wearable monitor and a SGC in ambulatory CHF patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 4, 2021

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 8, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

October 10, 2021

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2022

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 25, 2022

Completed
Last Updated

July 20, 2022

Status Verified

December 1, 2021

Enrollment Period

8 months

First QC Date

July 4, 2021

Last Update Submit

July 19, 2022

Conditions

Keywords

Non-Invasive MonitoringCardiac Output

Outcome Measures

Primary Outcomes (1)

  • Comparison of cardiac output obtained by a non-unvasive device to the invasive method

    In each participant, a Swan-Ganz catheter will be inserted as part of their routine assessment, and cardiac output measurements will be compared with a non-invasive wearable and wireless PPG-based device.

    2-4 hours per patient

Interventions

non-invasive measurements of cardiac output

Eligibility Criteria

Age18 Years - 120 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients from both sexes with CHF arriving for an ambulatory assessment using a Swan-Ganz catheter in the Medical Center's Cath-lab.

You may qualify if:

  • Patients with CHF

You may not qualify if:

  • Pregnant women
  • Pediatric patients
  • Inability to sign an informed consent form

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Hadassah Ein Kerem Medical Center

Jerusalem, 91120, Israel

Location

Related Publications (1)

  • Nachman D, Eisenkraft A, Rahamim E, Ibrahimli M, Asenov A, Goldstein N, Kolben Y, Huly S, Ben Ishay A, Fons M, Tabi M, Merin R, Amir O, Asleh R. Assessing Cardiac Flow Measurements Using a Noninvasive Photoplethysmography-Based Device Compared to Invasive Pulmonary Artery Catheter. JACC Adv. 2025 Sep;4(9):102093. doi: 10.1016/j.jacadv.2025.102093. Epub 2025 Aug 22.

MeSH Terms

Conditions

Cardiac Output, LowCardiac Output, HighHeart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Dean Nachman, MD

    The Institute for Research in Military Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 4, 2021

First Posted

July 8, 2021

Study Start

October 10, 2021

Primary Completion

June 15, 2022

Study Completion

June 25, 2022

Last Updated

July 20, 2022

Record last verified: 2021-12

Locations